Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
New Poll: Voters Want Federal Government to…
WASHINGTON, DC (October 17, 2024 ) -- More than eight in ten voters believe that it's important for the National Institutes of Health to devote additional resources to understanding health conditions that primarily impact women. That's among the key…
Learn more
BIO Urges Biden Administration to Work Alongside…
The Biotechnology Innovation Organization (BIO) released the following statement in response to a bipartisan letter signed by 21 members of the U.S. House of Representatives. Led by Reps. Randy Feenstra (R-IA) and Dan Kildee (D-MI), the letter urged…
Learn more
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Biotech Leader Testifies Before House Capital Markets Subcommittee
May 23, 2018
Washington, DC (May 23, 2018) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial…
Biotech in Our Backyard Panel to Highlight Agricultural Innovation in New England Region
May 23, 2018
Washington, D.C. (May 23, 2018) - Even with the abundance of high-profile international companies that will converge in Boston for the 2018 BIO International Convention, it’s difficult to overstate the work that is being done in Boston’s backyard…
BIO 2018 to Feature Rob Reiner as Keynote Speaker
May 21, 2018
Aactor, director and advocate Rob Reiner will deliver a keynote address at the 2018 BIO International Convention, the world’s premier life sciences event being held in Boston, June 4-7. Reiner’s family story of drug addiction reinforces the urgent…
Food Evolution Writer/Producer Trace Sheehan to Keynote Food & Ag Program at BIO Int’l Convention
May 16, 2018
Washington, D.C. (May 16, 2018) – Trace Sheehan, writer and producer of the highly-acclaimed documentary film Food Evolution, will be a keynote speaker at BIO’s International Convention in Boston, the Biotechnology Innovation Organization (BIO)…
BIO Statement on Trump Administration’s Plan to Lower Drug Costs
May 11, 2018
“We have concerns that some of the ideas proposed today could, if adopted, hurt patient access to the medicines they need …”
BIO’s Statement on PTO’s Proposed Changes to the Claim Construction Standard for PTAB Proceedings
May 9, 2018
Washington, D.C. (May 9, 2018) – Biotechnology Innovation Organization President for Advocacy, Law & Public Policy Tom DiLenge today issued the following statement in response to the U.S. Patent and Trademark Office’s (PTO) proposed change to…
BIO Thanks President Trump for Rejecting RIN Cap, Supporting E15
May 8, 2018
BIO thanked President Trump and Senators Charles Grassley (R-IA) and Joni Ernst (R-IA) for rejecting a price cap on Renewable Identification Numbers (RINs) and working to provide regulatory relief to enable year-round sales of E15.
BIO Launches New Report Profiling 100 Renewable Chemical Technology Companies
May 2, 2018
BIO's new “Renewable Chemical Platforms Building the Biobased Economy” report documents the rapid expansion of renewable chemical platforms and applications around the world, profiling 100 companies from 16 countries that are commercializing…
Wisconsin Governor Walker Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines
April 30, 2018
Washington, D.C. (April 10, 2018) – The Biotechnology Innovation Organization (BIO) and BioForward Wisconsin commend Governor Scott Walker for signing critical legislation to create a pathway for the substitution of interchangeable biologic…
BIO Applauds Introduction of the Opioid Addiction Action Plan Act
April 27, 2018
Washington, DC (April 27, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the Opioid Addiction Action Plan Act, introduced yesterday in the Senate by Senators Heller (R-NV), Isakson (R-GA), and Menendez (D…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today